Aurobindo Pharma gets FDA nod and other Top Corporate News
indiainfoline | May 17, 2016
BHEL has bagged a Rs16bn order from a joint-venture company of NTPC and SAIL to set up a coal-based thermal power project in Odisha. (BS) Aurobindo Pharma has received final nod from the US health regulator to manufacture and market its anaesthetic Bupivacaine Hydrochloride injection in the American market. (BL) Piramal Enterprises has decided to demerge its healthcare and financial services businesses to grow the unrelated divisions separately, marking an important turn in the legacy of the diversified conglomerate.